senicapoc (ICA-17043)
Jump to navigation
Jump to search
Indications
Mechanism of action
- long-acting Gardos-channel blocker
- inhibits K+ efflux
More general terms
References
- ↑ Ataga KI, Smith WR, De Castro LM, Swerdlow P et al Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood. 2008 Apr 15;111(8):3991-7. Epub 2008 Jan 11. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18192510
- ↑ Joiner CH. Gardos pathway to sickle cell therapies? Blood. 2008 Apr 15;111(8):3918-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18434967